Achievements and obstacles of remyelinating therapies in multiple sclerosis. (2017)

First Author: Stangel M
Attributed to:  Capital award for UK DRI at Imperial College London funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nrneurol.2017.139

PubMed Identifier: 29146953

Publication URI: http://europepmc.org/abstract/MED/29146953

Type: Journal Article/Review

Volume: 13

Parent Publication: Nature reviews. Neurology

Issue: 12

ISSN: 1759-4758